Lack of direct bone effect of tofacitinib, a JAK inhibitor, in juvenile rats and evaluation of the association between offspring growth and femur length.

Saved in:
Bibliographic Details
Title: Lack of direct bone effect of tofacitinib, a JAK inhibitor, in juvenile rats and evaluation of the association between offspring growth and femur length.
Authors: Campion, SN.1 (AUTHOR) sarah.campion@pfizer.com, Potter, DM.2 (AUTHOR), Bowman, CJ.1 (AUTHOR), Catlin, NR.1 (AUTHOR), Davis, S.3 (AUTHOR), Millard, C.3 (AUTHOR), Nowland, WS.1 (AUTHOR), Stethem, CM.1 (AUTHOR), Hollingshead, BD.2 (AUTHOR), Radi, ZA.2 (AUTHOR), Coder, PS.3 (AUTHOR), Cappon, GD.1 (AUTHOR)
Source: Reproductive Toxicology. Oct2022, Vol. 113, p35-41. 7p.
Database: Environment Complete
Description
ISSN:08906238
DOI:10.1016/j.reprotox.2022.08.002